To include your compound in the COVID-19 Resource Center, submit it here.

AstraZeneca reports earnings

AstraZeneca plc (LSE:AZN; NYSE:AZN) reported 2Q11 core EPS of $1.73, missing by $0.07 the

Read the full 140 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE